BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -10.78%473.81M | -24.27%404.11M | -4.76%509.76M | 81.36%528.03M | 117.14%531.06M | 116.76%533.63M | 47.37%535.22M | -36.84%291.15M | -52.78%244.57M | -50.23%246.19M |
Notes receivable and accounts receivable | 5.80%385.65M | 42.62%417.4M | 66.64%434.63M | -16.86%388.13M | -19.05%364.52M | -32.75%292.66M | -34.89%260.83M | 15.93%466.82M | 27.00%450.32M | 24.63%435.19M |
-Notes receivable | ---- | --50M | ---- | ---- | ---- | ---- | ---- | --50M | ---- | --74M |
-Accounts receivable | 5.80%385.65M | 25.54%367.4M | 66.64%434.63M | -6.88%388.13M | -19.05%364.52M | -18.97%292.66M | -34.89%260.83M | 3.51%416.82M | 27.00%450.32M | 3.44%361.19M |
Other receivables (including interest and dividends) | -13.76%4.09M | 8.45%3.65M | -21.61%4.07M | -31.38%3.84M | -13.70%4.74M | -27.44%3.37M | 39.27%5.19M | 29.28%5.59M | -3.98%5.5M | 26.03%4.64M |
-Other receivable | ---- | 8.45%3.65M | ---- | -31.38%3.84M | ---- | -27.44%3.37M | ---- | 29.28%5.59M | ---- | 26.03%4.64M |
Contractual assets | 289.36%10.4M | -37.33%13.29M | -83.50%1.59M | -57.89%5.77M | 41.26%2.67M | -24.11%21.21M | 65.94%9.63M | 51.03%13.69M | -57.88%1.89M | 20.23%27.94M |
Advance payment | 16.14%8.49M | 139.28%6.6M | -23.50%13.26M | -4.75%8.74M | -19.72%7.31M | -42.08%2.76M | 66.68%17.33M | 37.18%9.18M | -3.09%9.1M | -29.58%4.77M |
Inventories | -13.99%66.88M | -1.37%65.6M | -1.19%67.26M | 5.89%77.49M | -2.86%77.76M | -13.40%66.51M | -3.26%68.07M | -13.54%73.18M | 10.70%80.04M | 26.20%76.8M |
Other current assets | 3,548.63%2.12M | -58.41%1.95M | --226.97K | -65.63%1.75M | -93.86%58.22K | -35.91%4.68M | ---- | 94.55%5.09M | -68.26%948.35K | 25.38%7.31M |
Total current assets | -3.71%951.44M | -1.32%912.61M | 15.01%1.03B | 17.23%1.01B | 24.70%988.12M | 15.19%924.83M | 4.94%896.27M | -10.94%864.71M | -18.09%792.37M | -14.97%802.85M |
Non Current assets | ||||||||||
Other non-current financial assets | -9.80%452.97M | -9.80%452.97M | -23.59%453.56M | -23.59%453.56M | -4.06%502.18M | 16.11%502.18M | 37.21%593.58M | 37.21%593.58M | 23.55%523.41M | 2.09%432.5M |
Investment real estate | 206.91%16.95M | 202.55%17.48M | 198.55%18M | -16.08%5.27M | -15.46%5.52M | -14.88%5.78M | -14.35%6.03M | -13.85%6.28M | -13.39%6.53M | -12.95%6.79M |
Long-term equity investment | 1.58%654.91K | -0.92%588.39K | 1.74%544.66K | 21.00%786.09K | 4.45%644.74K | 4.70%593.88K | 5.27%535.36K | 40.60%649.65K | 10.49%617.29K | 9.65%567.24K |
Fixed assets | ---- | -7.03%2.41B | ---- | -6.58%2.5B | ---- | -0.82%2.59B | ---- | 11.73%2.68B | ---- | 5.17%2.61B |
Fixed assets liquidation | ---- | --7.27K | ---- | ---- | ---- | ---- | ---- | -65.65%10.75K | ---- | ---- |
Constru in process | ---- | 11,917.93%116.11M | ---- | -43.02%4.37M | ---- | -99.23%966.12K | ---- | -97.49%7.68M | ---- | -47.14%126.11M |
Intangible assets | -10.91%2.31B | -10.59%2.38B | -8.75%2.45B | -8.21%2.52B | -7.70%2.59B | -7.22%2.67B | -7.39%2.68B | -6.91%2.75B | -6.44%2.81B | -5.99%2.87B |
Long deferred expense | --1.6M | --1.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Deferred tax assets | -61.83%8.85M | -61.83%8.85M | 302.68%33.76M | 292.72%32.92M | 176.55%23.18M | 174.77%23.18M | 4.56%8.38M | 4.56%8.38M | 4.56%8.38M | 5.24%8.44M |
Usufruct assets | 284.78%103.99M | -39.19%20.78M | 103.66%23.3M | 79.44%24.93M | 56.02%27.03M | 57.40%34.17M | -69.84%11.44M | -69.72%13.89M | -66.33%17.32M | -68.13%21.71M |
Other non current assets | ---- | ---- | --146.53K | -30.97%146.53K | --146.53K | 24.59%264.46K | ---- | --212.26K | ---- | --212.26K |
Total non current assets | -5.69%5.37B | -7.09%5.41B | -8.61%5.43B | -8.43%5.54B | -6.44%5.7B | -4.24%5.82B | -2.82%5.94B | -1.51%6.05B | -1.86%6.09B | -3.28%6.08B |
Total assets | -5.40%6.33B | -6.30%6.32B | -5.51%6.46B | -5.22%6.56B | -2.85%6.69B | -1.98%6.75B | -1.87%6.84B | -2.80%6.92B | -4.04%6.88B | -4.81%6.88B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -84.09%35.02M | -64.45%80.06M | -74.98%55.09M | -6.83%205.15M | -0.01%220.18M | 18.40%225.21M | 75.96%220.19M | 62.93%220.19M | 31.18%220.21M | 68.56%190.21M |
Notes payable and accounts payable | 46.95%268.27M | 44.11%281.94M | 97.41%228.31M | 46.09%255.83M | -3.29%182.55M | -15.13%195.64M | -29.83%115.65M | 16.23%175.12M | 20.92%188.77M | -0.26%230.53M |
-Notes payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30M | ---- | ---- |
-Accounts payable | 46.95%268.27M | 44.11%281.94M | 97.41%228.31M | 76.28%255.83M | -3.29%182.55M | -15.13%195.64M | -29.83%115.65M | -3.68%145.12M | 20.92%188.77M | -0.26%230.53M |
Contract liabilities | -98.36%37.74K | 50.21%3.23M | -45.35%842.39K | 335.56%3.63M | 58.77%2.3M | 160.16%2.15M | -3.65%1.54M | -91.62%833.75K | -63.06%1.45M | -65.72%825.69K |
Advance receipts | -59.45%388.89K | 5.00%388.89K | 5.00%388.89K | ---- | 158.96%959.11K | 0.00%370.37K | -36.02%370.37K | ---- | 0.00%370.37K | 0.00%370.37K |
Salaries payable | -42.64%30.43M | -61.63%17.56M | 3.64%75.17M | 14.44%64.22M | 32.71%53.05M | 42.87%45.78M | 10.12%72.53M | 17.01%56.12M | 10.05%39.97M | 36.83%32.04M |
Taxs payable | -46.78%9.18M | -61.42%11.63M | -63.50%12.51M | -64.38%9.95M | 66.22%17.25M | 158.34%30.16M | 35.79%34.29M | 17.91%27.94M | -73.63%10.38M | -86.33%11.67M |
Other payable (including interest and dividends) | -35.70%39.12M | -40.25%17.56M | 74.66%153.32M | -52.14%58.51M | 23.02%60.84M | 34.33%29.39M | -29.55%87.78M | -40.83%122.24M | 27.62%49.46M | 37.25%21.88M |
-Dividend payable | ---- | ---- | --67.67M | 1.53%36.75M | ---- | ---- | ---- | -75.13%36.2M | ---- | ---- |
-Other payable | ---- | -40.25%17.56M | ---- | -74.71%21.76M | ---- | 34.33%29.39M | ---- | 40.88%86.04M | ---- | 37.25%21.88M |
Non current liabilities due within one year | 128.70%129.63M | 13.19%111.67M | -34.56%99.58M | -43.68%104.06M | -73.44%56.68M | -60.44%98.66M | -18.93%152.16M | 2.44%184.75M | 13.84%213.39M | -2.46%249.42M |
Other current liabilities | -28.05%759.93K | -88.44%29.04K | 4.06%749.9K | 6.73%957.73K | 44.70%1.06M | 238.07%251.23K | -13.35%720.62K | 22.59%897.35K | --729.93K | 125.00%74.31K |
Total current liabilities | -13.79%512.84M | -16.50%524.08M | -8.65%625.96M | -10.89%702.31M | -17.92%594.88M | -14.85%627.61M | -1.60%685.23M | 4.37%788.1M | 15.01%724.73M | 1.34%737.02M |
Current liabilities | ||||||||||
Long term loan | -27.57%617.78M | -27.57%617.78M | -24.52%670.14M | -26.99%670.14M | -13.20%852.9M | -13.20%852.9M | -20.27%887.81M | -21.78%917.81M | -22.77%982.58M | -22.77%982.58M |
Deferred tax liabilities | -48.47%8.28M | -48.47%8.28M | 12.68%26.63M | 8.62%25.67M | -28.86%16.06M | -29.02%16.06M | 4.59%23.63M | 4.59%23.63M | 10.86%22.57M | 11.12%22.62M |
Long term deferred income | -8.29%35.18M | -8.29%35.18M | -6.31%38.36M | 18.74%38.36M | 18.74%38.36M | 18.74%38.36M | 27.67%40.94M | 0.73%32.3M | 0.73%32.3M | 0.73%32.3M |
Lease liabilities | 238.84%82.54M | -23.64%14.93M | 77.93%16.36M | 38.30%23.2M | 54.55%24.36M | 28.97%19.56M | -54.58%9.2M | -45.44%16.78M | -57.62%15.76M | -67.03%15.16M |
Total non current liabilities | -20.17%743.77M | -27.05%676.17M | -21.85%751.49M | -23.54%757.37M | -11.54%931.68M | -11.95%926.87M | -19.09%961.58M | -21.31%990.52M | -22.66%1.05B | -23.20%1.05B |
Total liabilities | -17.68%1.26B | -22.79%1.2B | -16.36%1.38B | -17.93%1.46B | -14.14%1.53B | -13.14%1.55B | -12.62%1.65B | -11.68%1.78B | -10.75%1.78B | -14.69%1.79B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B |
Capital reserve funds | 0.00%1.19B | 0.00%1.19B | 0.00%1.19B | 0.00%1.19B | 0.00%1.19B | 0.00%1.19B | 0.00%1.19B | 0.00%1.19B | 0.00%1.19B | 0.00%1.19B |
Surplus reserve funds | 1.78%315.91M | 1.78%315.91M | 2.63%310.37M | 2.63%310.37M | 2.63%310.37M | 2.63%310.37M | 5.86%302.41M | 5.86%302.41M | 5.86%302.41M | 5.86%302.41M |
Retained profit | -3.34%1.2B | -1.55%1.25B | -4.94%1.22B | -0.97%1.21B | 3.24%1.24B | 5.64%1.27B | 6.47%1.28B | 4.02%1.22B | -2.21%1.2B | 0.04%1.2B |
Other composite income | 96.92%2.61M | 146.21%2.85M | -97.55%53.97K | -32.34%1.8M | 200.24%1.32M | 491.48%1.16M | 124.40%2.2M | 184.60%2.66M | 80.45%-1.32M | 95.44%-295.89K |
Specific reserves | 6.18%1.24M | ---- | 165.18%2.6M | 9.03%1.77M | -3.53%1.16M | ---- | 54.93%978.7K | 60.73%1.62M | 0.57%1.21M | ---- |
Shareholders equity without minority interests | -0.88%3.91B | -0.31%3.96B | -1.41%3.93B | -0.12%3.92B | 1.27%3.95B | 1.98%3.97B | 2.48%3.98B | 1.83%3.92B | -0.13%3.9B | 0.60%3.89B |
Minority interests | -4.66%1.16B | -4.80%1.16B | -4.26%1.15B | -3.11%1.18B | 0.47%1.21B | 1.84%1.22B | 0.93%1.21B | -2.76%1.22B | -5.56%1.21B | -4.97%1.2B |
Total shareholder equity | -1.76%5.07B | -1.37%5.12B | -2.07%5.08B | -0.83%5.1B | 1.08%5.16B | 1.95%5.19B | 2.11%5.19B | 0.70%5.14B | -1.47%5.11B | -0.77%5.09B |
Total liabilityies and equity | -5.40%6.33B | -6.30%6.32B | -5.51%6.46B | -5.22%6.56B | -2.85%6.69B | -1.98%6.75B | -1.87%6.84B | -2.80%6.92B | -4.04%6.88B | -4.81%6.88B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.